African Analyst

Tuesday, August 4, 2026

WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership

BOSTON - Tuesday, 04. August 2026

The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership.

(BUSINESS WIRE)--WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control.

The Natural Cycles app, a Class II medical device, uses biomarker data, including temperature and heart rate data, to identify fertile and non-fertile days, helping users prevent pregnancy without hormones while also providing fertility insights. Beyond birth control, the app also supports users through pregnancy planning, pregnancy, postpartum, and perimenopause with dedicated modes tailored to each stage of their reproductive journey.

This integration and exclusive offer advance the efforts of WHOOP in women’s health by combining continuous physiological data with clinically validated fertility technology. Women are one of the fastest-growing segments of WHOOP members, with membership growing 111% year over year. As demand grows for personalized health insights and non-hormonal reproductive health options, this integration gives WHOOP members a more seamless way to understand fertility alongside the recovery, sleep, and health insights already available through WHOOP.

"This partnership represents a commitment to supporting women's health through clinically-backed, actionable data," said Dr. Ami Bhatt, WHOOP Chief Medical Officer. "By integrating with the NC° app, we are providing our members with a seamless way to access personalized reproductive health insights, expanding WHOOP beyond performance into everyday health."

"At Natural Cycles, we're committed to making digital contraception as seamless as possible for our users," said Dr. Magda Armbruster, VP of Product at Natural Cycles. "Integrating with WHOOP removes friction from the experience by allowing members to use the wearable they already rely on to automatically capture overnight skin temperature used by the NC° app to determine daily fertility status. It's another step toward making hormone-free birth control fit more naturally into everyday life."

Membership Benefits:

A 12-month subscription to the NC° app included with any WHOOP membership for members new to Natural Cycles.

Automatic overnight skin temperature sharing with the NC° app through compatible WHOOP devices.

Daily fertility status inside the world's only FDA-cleared digital birth control app.

Features designed by Natural Cycles° to support women throughout the reproductive journey—from birth control and pregnancy planning to pregnancy, postpartum, and perimenopause.

The integration is currently available for users with WHOOP MG and 5.0 devices. WHOOP and Natural Cycles° remain committed to the highest standards of privacy and data security, ensuring that sensitive health information is managed with the utmost care.

To learn more about WHOOP, please visit whoop.com. To access visuals, please visit the Digital Press Kit.

About WHOOP

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.

Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $950 million in venture capital, ships to 56 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.

About Natural Cycles°

Founded in 2013 by physicists Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles is a leading women's digital health company dedicated to transforming how women understand and manage their reproductive health. The company developed the world's first FDA-cleared digital method of birth control, delivered through an app and powered by a proprietary algorithm that interprets biomarker data, including body temperature, to provide personalized cycle insights and a daily fertility status. The NC° Birth Control app is an FDA-cleared Class II medical device with six FDA clearances and has also received regulatory authorizations in Europe, Canada, Brazil, Australia, Singapore, and South Korea.

With a single subscription, the Natural Cycles app offers five dedicated modes—NC° Birth Control, NC° Plan Pregnancy, NC° Follow Pregnancy, NC° Postpartum, and NC° Perimenopause—supporting women throughout their reproductive lives. Trusted by more than six million registered users worldwide and backed by 30 peer-reviewed studies, Natural Cycles continues to pioneer science-driven, non-invasive innovations that expand access to personalized reproductive health tools and empower women to take control of their reproductive health.

Learn more at Naturalcycles.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260804399367/en/

Permalink

https://www.aetoswire.com/en/news/54582456

Contacts

Press Contact

Jack Taylor Worldwide

Whoop@jacktaylorpr.com

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

SAN DIEGO - Tuesday, 04. August 2026 AETOSWire Print

(BUSINESS WIRE)--LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3

KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5

The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The first FDA approval of a menin inhibitor for relapsed or refractory acute leukemia with a KMT2A translocation established clinical validation for this emerging drug class.7 As menin inhibitor programs move into frontline and combination studies, there is an increasing need for sensitive molecular testing that can accurately characterize KMT2Ar, quantify deep molecular response, and track response durability over time.

Standardized MRD Testing for Global Clinical Development

LabPMM’s new test targets the most common KMT2A partner fusion genes in AML and ALL,8 aligning the assay with the KMT2A biology central to many current menin inhibitor development programs. The test provides a quantitative result reported as the percentage of KMT2Ar relative to a housekeeping gene. The assay supports disease characterization and longitudinal MRD monitoring with sensitivity down to 0.005% and a turnaround time in as little as 48 hours.9 This launch expands Invivoscribe’s comprehensive myeloid testing portfolio, which includes globally standardized molecular assay kits and LabPMM services for screening and MRD monitoring of FLT3, NPM1, KMT2Ar, as well as AML MRD assessment by multiparametric flow cytometry. Together, these integrated capabilities enable drug developers and healthcare providers to monitor disease burden over time with unprecedented sensitivity and accuracy.

“Menin inhibitors are creating important new possibilities for patients with KMT2A-rearranged leukemia, but continued development requires a partner that can deliver highly sensitive, standardized molecular data across clinical programs and geographies,” said Jeff Miller, CEO and CSO of Invivoscribe. “By making KMT2A MRD testing available through LabPMM, we are helping clinicians and biopharmaceutical partners measure meaningful responses earlier, monitor their durability, and ultimately improve patient care.”

Together, Invivoscribe and LabPMM provide an integrated global ecosystem of standardized MRD testing, regulatory expertise, and companion diagnostic capabilities. Highly sensitive MRD testing can help define molecular response depth, evaluate response durability, support patient stratification, and accelerate trials when used as surrogate endpoints. By generating consistent molecular data across global clinical programs, this integrated approach helps sponsors make earlier, more informed decisions and reduce development risk from early clinical studies through regulatory submission, approval, and commercialization.

Healthcare providers and biopharmaceutical sponsors developing menin inhibitors for acute leukemia or other immunotherapies can contact Invivoscribe to discuss our global testing programs. Visit www.invivoscribe.com or contact inquiry@invivoscribe.com

About Invivoscribe

Invivoscribe® is a global, vertically integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics®. For over thirty years, Invivoscribe has improved the quality of healthcare worldwide by providing high-quality standardized reagents, tests, and bioinformatics tools to advance the field of precision medicine. Invivoscribe has a successful track record of partnerships with pharmaceutical companies interested in clinical trial testing via our global lab network located in the U.S., Germany, Japan, and China, and in developing and commercializing companion diagnostics, with rigorous expertise in both regulatory and laboratory services. Providing distributable kits, as well as clinical trial services through its globally located clinical lab subsidiaries, LabPMM®, Invivoscribe is an ideal partner from diagnostic development through clinical trials, regulatory submissions, and commercialization.

References

Dillon, L. et al. JAMA Oncol. 2024;10;(8):1104-1110. https://doi.org/10.1001/jamaoncol.2024.0985

Levis, M., et al. Blood. 2025;145(19):2138-2148 https://doi.org/10.1182/blood.2024025154

Hourigan CS, et al. Blood. 2025;145(19)2105-2106. https://doi.org/10.1182/blood.2024028105

Petersen, L. et al. J Mol Diag. 2025;27(10)989-1002. https://doi.org/10.1016/j.jmoldx.2025.06.007

Yin, L. et al. Cancer Med. 2024;13(20):e70326. https://doi.org/10.1002/cam4.70326

Al-Ali, R. et al. Bone Marrow Transplant. 2025;61:222-224. https://doi.org/10.1038/s41409-025-02757-1

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-revumenib-relapsed-or-refractory-acute-leukemia-KMT2A-translocation

Additional KMT2A partner fusion genes will be added in early 2027 further expanding ALL coverage.

MRD results from our KMT2A, FLT3-ITD, and NPM1 assays can be reported in as little as 48 hours, although standard turnaround time is 7-10 business days.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803738654/en/

Permalink

https://www.aetoswire.com/en/news/54582770

Contacts

inquiry@invivoscribe.com

1-866-623-8105

Kioxia to Showcase CXL™ Compatible Memory Expansion Module KIOXIA XL1 Series for AI Workloads

TOKYO - Monday, 03. August 2026

(BUSINESS WIRE) -- Kioxia Corporation, a world leader in memory solutions, today announced that it will exhibit the KIOXIA XL1 series, a Compute Express Link™ (CXL™) compatible memory expansion module, at the Kioxia booth at FMS: the Future of Memory and Storage, taking place August 4 - 6 in Santa Clara, CA. The product features KIOXIA XL-FLASH™, a low-latency and high-performance flash memory technology that enables flash memory, traditionally used for storage applications, to also be utilized as a memory expansion solution. In addition, it is being designed and developed to support the growing volume of memory-intensive AI applications. Evaluation samples are scheduled to be shipped to industry ecosystem collaborators in August 2026.

In recent years, the growing number of AI workloads has significantly increased memory demand in data centers, creating serious challenges such as capacity shortages and rising costs. In response to this important market need, Kioxia is targeting an innovative memory expansion solution for hyperscale environments. The KIOXIA XL1 series memory expansion module combines low-latency, high-performance XL-FLASH™ with a CXL™ interface and improves DRAM utilization efficiency by placing less frequently accessed data on the module. It bridges the performance and cost gap between conventional DRAM and SSDs, enabling memory expansion for demanding AI applications.

Note: The sample drives are for evaluation purposes only. Some functions may not have been fully tested, and specifications are subject to change.

NIQ Returns to IFA 2026 to Lead Industry Conversations on Growth, Innovation, AI and Consumer Transformation

Exclusive insights, executive thought leadership and industry dialogue at the IFA Retail Leaders Summit and NIQ Business Breakfast

(BUSINESS WIRE) -- As the Official Global Insights Partner of IFA Berlin 2026, NIQ (NYSE: NIQ) will continue to play a leading role shaping industry discussions , bringing together data, AI-driven intelligence, and human insight to illuminate the forces reshaping growth, innovation, and consumer behavior. Through executive keynotes, panel discussions, exclusive market intelligence, and strategic customer engagements (including participation in the IFA Retail Leaders Summit, the fourth NIQ Business Breakfast, and a dedicated SMB-focused event) NIQ will help translate rapid market change into actionable opportunity for the global technology ecosystem.

Under this year’s IFA theme, “The Future Is Now,” NIQ will provide timely perspectives on the forces redefining consumer technology, home appliances, and retail—from AI-driven innovation and evolving shopper expectations to omnichannel transformation and emerging growth opportunities.

As brands and retailers navigate economic uncertainty, shifting purchase behavior, and increasing price sensitivity, NIQ’s latest market data highlights both the challenges and opportunities facing the sector. While Tech and Durables markets remain under pressure in some regions, growth continues to emerge across key European markets, reinforcing the importance of innovation, agility, and data-driven decision-making.

“IFA is where the future of the industry takes shape,” said Perry James, SVP, Global Tech & Durables, NIQ. “We’re entering a new era where data, AI, and consumer behavior are converging, and the rules of growth are being rewritten in real time. The question isn’t whether the industry will change, but who will have the intelligence to lead it. NIQ is bringing insights designed to help the industry move from analysis to action.”

IFA 2026 Event Programme: AI, Innovation and the Future of Growth

NIQ will bring its latest AI-driven insights and market intelligence to IFA 2026 through a series of high-impact engagements designed to explore the forces reshaping technology and retail.

IFA Retail Leaders Summit (3 September)

NIQ will join senior retail and technology executives to discuss how AI, data and evolving consumer behaviors are transforming the future of commerce. In a keynote session, NIQ will share insights into the forces reshaping the Tech & Durables industry, drawing on global market intelligence and consumer trends to highlight how businesses can drive sustainable growth through AI-powered decision-making, omnichannel strategies and next-generation retail models in an increasingly complex marketplace. More information here.

The Intelligence Edge: How Emerging Tech Brands Compete and Win (4 September)

An SMB-focused session on where growth is emerging, how challengers are winning share, and what distribution shifts reveal about broader market transformation—followed by a networking reception with NIQ experts. More information here.

NIQ Business Breakfast: Reset 2026—Disruption, New Players and the Future of the Tech Industry (5 September)

NIQ’s Business Breakfast will bring together industry leaders to examine a market in transition, where social commerce, marketplaces, D2C channels, and AI-powered experiences are reshaping how consumers discover and buy. The discussion will focus on how brands and retailers can adapt—through emerging commerce ecosystems, platform-agnostic journeys, and stronger control of the customer experience in an AI-driven world. More information here.

FAQs

1. What is NIQ’s role at IFA 2026?

NIQ is the Official Global Insights Partner of IFA Berlin 2026 and will lead industry conversations through executive keynotes, panel discussions, and exclusive market intelligence focused on growth, AI-driven innovation, and consumer transformation.

2. What insights will NIQ share at IFA 2026?

NIQ will provide AI-driven and data-powered insights on the forces reshaping consumer technology, home appliances, and retail—including omnichannel commerce, evolving shopper behavior, retail media, and emerging growth opportunities.

3. Which events will NIQ participate in at IFA 2026?

NIQ will participate in the IFA Retail Leaders Summit (3 September) and host the Intelligence Edge SMB-focused session (4 September) as well as NIQ Business Breakfast (5 September), each addressing different dimensions of AI, innovation, and market transformation.

4. How is AI influencing the technology and retail sectors according to NIQ?

AI is accelerating change across the ecosystem, reshaping how consumers discover and purchase products, enabling more advanced decision-making, and creating new opportunities for brands and retailers to drive growth through data and intelligence.

About NIQ

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.

With operations in more than 90 countries, NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next.

For more information, please visit www.niq.com.

Forward Looking Statement

This press release includes forward-looking statements that reflect NIQ’s current expectations and projections about future market trends and consumer behavior. These statements are based on available information and reasonable assumptions but are subject to risks and uncertainties that could cause actual results to differ. NIQ does not undertake to update these statements, except as required by law.

Disclaimer

All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

NIQ-GENERAL

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803586988/en/

Permalink

https://www.aetoswire.com/en/news/0308202656582

Contacts

Julia Mayer, julia.mayer@nielseniq.com

First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC

WINDSOR, Conn. -

(BUSINESS WIRE) -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*.

“As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.”

The engagement highlights the breadth and scalability of SS&C’s global service model. Leveraging SS&C’s integrated investment operations solution, First Plus will modernize its investment operations and bolster cross-jurisdictional compliance across Asia. The solution will streamline the process for front-office teams to trade and manage portfolio exposures and manage investor accounting and reconciliation. SS&C will also provide transfer agency services in Thailand, supporting FPAM’s investor servicing and recordkeeping. FPAM will also gain access to SS&C’s integrated automation capabilities to optimize and streamline operations.

“We are thrilled to further our relationship with First Plus as their business continues to grow,” said Damien Barry, Head of Asia Pacific, Africa & Middle East for SS&C Global Investor & Distribution Solutions. “As asset management continues to globalize and offer new and complex fund vehicles, we are seeing an increased demand for cross-border operations and compliance support. We look forward to working with First Plus to streamline and integrate their workflows through our scalable global ecosystem, so the First Plus team can focus on growth and investor experiences.”

*As of June 30, 2026

About First Plus Asset Management

Based in Singapore, First Plus Asset Management Pte. Ltd. is a licensed asset management firm focused on the Asia-Pacific market. The firm holds a Capital Markets Services (CMS) Fund Management License from the Monetary Authority of Singapore (MAS) and has been recognized with key regulatory qualifications, including Qualified Foreign Institutional Investor (QFII) status granted by the China Securities Regulatory Commission (CSRC) and approval for Bond Connect by the People’s Bank of China (PBOC).

First Plus Asset Management (Thailand) Company Limited, an affiliated entity within the group, is licensed by Thailand’s Ministry of Finance to manage public mutual funds, private funds, and provident funds. It’s also recognized by the CSRC as a QFII.

Combining global perspectives with deep regional expertise, the First Plus group delivers sustainable, long-term growth through its capabilities in structured credit, quantamental strategies, and other diversified investment solutions.

About SS&C Technologies

SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.

Follow SS&C on X, LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260802033024/en/

Permalink

https://www.aetoswire.com/en/news/0308202656578

Contacts

Brian Schell | Chief Financial Officer, SS&C Technologies

Tel: +1-816-642-0915 | E-mail: InvestorRelations@sscinc.com

Justine Stone | Investor Relations, SS&C Technologies

Tel: +1-212-367-4705 | E-mail: InvestorRelations@sscinc.com

Media Contacts

Madison Gallo

Prosek Partners

Email: pro-SSC@prosek.com

Thales Launches Imperva for AWS to Help Organizations Protect Applications and APIs

Imperva for AWS delivers enterprise-grade web application, API, and bot protection for AWS environments

Using Amazon CloudFront, AWS's fully managed content delivery network, to simplify deployment while strengthening application security

Reduces operational complexity with centralized security visibility and policy management across AWS and multi-cloud environments

(BUSINESS WIRE) -- Thales today announced the availability of Imperva for AWS, bringing its industry-leading web application firewall (WAF) to Amazon Web Services, Inc. (AWS) Marketplace as a SaaS offering. Built on key AWS services, Imperva for AWS helps organizations protect web applications and APIs against common cyber threats and malicious bot activity.

The 2026 Thales Bad Bot Report found that automated traffic now accounts for 53% of all internet requests, with 27% of bot attacks targeting APIs directly. As attackers increasingly bypass user interfaces to operate at machine speed, organizations need application security that can keep pace without adding complexity.

Imperva WAF delivers enterprise-grade protection natively on Amazon CloudFront. Unlike legacy content delivery network WAFs that route traffic outside the cloud provider network, Imperva WAF deploys directly on Amazon CloudFront, keeping all traffic within the AWS network with zero added latency. Available on AWS Marketplace with pay-as-you-go pricing.

Organizations can benefit from:

Enterprise-grade protection for web applications, APIs, and client-side code

Simplified deployment through Amazon CloudFront

Centralized visibility and policy management across AWS and multi-cloud environments

Faster onboarding with reduced operational complexity

Consistent application security that scales with cloud growth

“Imperva for AWS makes it easy for customers to protect their applications and APIs with enterprise-grade security that works out of the box. By deploying natively on Amazon CloudFront’s 750+ Points of Presence, we keep all traffic within the AWS network, delivering protection at scale with zero added latency,” said Tim Chang, Vice President, Application Security, Thales.

Imperva for AWS is designed to help even the most highly regulated organizations secure modern applications without increasing operational overhead. By combining enterprise-grade protection with simplified deployment and centralized management, organizations can strengthen application, API and AI security while maintaining the agility needed to innovate in the cloud.

Imperva WAF is Thales’s latest advancement in its work with AWS. Customers can begin using Imperva WAF immediately here: AWS Marketplace.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies for the Defence, Aerospace, and Cyber & Digital sectors. Its portfolio of innovative products and services helps address several major challenges: sovereignty, security, sustainability and inclusion.

The Group allocates €4.5 billion per year in Research & Development in key areas, particularly for critical environments, such as Artificial Intelligence, Cybersecurity, Quantum and Cloud technologies. Thales has more than 85,000 employees in 65 countries. In 2025, the Group generated sales of €22.1 billion.

Recent images of Thales and its Defense, Aerospace and Cyber & Digital activities can be found on the Thales Media Library. For any specific requests, please contact the Media Relations team.

PLEASE VISIT

Thales Group

Cybersecurity Products| Thales Group

Cybersecurity Solutions | Thales Group

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803503864/en/

Permalink

https://aetoswire.com/en/news/0308202656585

Contacts

PRESS

Thales, Media Relations

Security & Cybersecurity

Marion Bonnet

+33 (0) 6 60 38 48 92

marion.bonnet@thalesgroup.com

Monday, August 3, 2026

MEX Exchange, Part of MultiBank Group Strengthens Leadership Team with Key Appointment

DUBAI, United Arab Emirates -

(BUSINESS WIRE) -- MEX Exchange, the institutional electronic trading platform of MultiBank Group, today announced the appointment of Vibhanshu Bahuguna as Senior Director, reinforcing the company's commitment to building a world-class leadership team as it expands its global institutional business and technology capabilities.

With more than 20 years of experience across sales, business development and electronic trading, Bahuguna joins MEX Exchange with extensive expertise in electronic trading solutions spanning EMS, OMS, OTC and ECN technologies across the foreign exchange and digital asset markets throughout the Asia-Pacific region.

Throughout his career, Vibhanshu has held senior leadership positions with some of the industry's most renowned institutions. He began his career at Bloomberg before joining TradingScreen, where he delivered multi-asset trading access solutions. He later managed the Currenex and FX Connect franchise for State Street across Southeast Asia before leading TradAir's Asia-Pacific business from 2015, driving the adoption of FX aggregation, pricing engine and white-label trading technology until the company's acquisition by ION Group in 2022. Most recently, he headed Sales and Business Development at Cypator ECN, working alongside TradAir's original co-founder to expand the platform's institutional footprint.

David Ogg, Chief Executive Officer of MEX Exchange, said: "We are delighted to welcome Vibhanshu to the team. He brings an exceptional combination of commercial leadership, market expertise, and deep relationships across the institutional trading ecosystem. His experience in building and scaling electronic trading businesses across the Asia-Pacific region will be instrumental as we continue expanding MEX Exchange's global presence."

Commenting on his appointment, Vibhanshu Bahuguna said: "MEX Exchange represents one of the most exciting opportunities in institutional electronic trading today. The vision, technology and leadership assembled by the team provide a unique platform to redefine institutional market access, and I look forward to contributing to the next phase of the company's growth."

Bahuguna's appointment further strengthens an already distinguished leadership team driving MEX Exchange's institutional business.

The team is led by David Ogg, one of the most influential pioneers in institutional foreign exchange trading and widely recognised. Over a career spanning more than four decades, Ogg founded HotspotFX, the industry's first institutional FX ECN, along with LavaFX and LiquiMatch, while leading groundbreaking innovations that have shaped today's electronic trading landscape. Under his leadership, MEX Exchange is developing an institutional trading venue powered by AI-driven execution capabilities, ultra-low-latency matching technology and institutional-grade infrastructure designed to serve global market participants.

Complementing the leadership team is Brian Andreyko, Chief Product Officer, who brings extensive experience across global markets and electronic trading. Having held senior leadership roles at Edgewater Markets, TradAir, ICAP and Currenex, he now oversees the strategic development of MEX Exchange's ECN, Technical Services and Execution Services businesses.

Together, the appointments reflect MEX Exchange's continued investment in attracting industry-leading talent as it builds a next-generation institutional trading ecosystem that combines advanced technology, deep market expertise and global connectivity to meet the evolving needs of institutional clients worldwide.

ABOUT MULTIBANK GROUP

MultiBank Group, established in California, USA in 2005, is a global leader in financial derivatives, serving over 2 million clients across 100 countries, and boasts a daily trading volume that exceeds $35 billion. Renowned for its innovative trading solutions, robust regulatory compliance, and exceptional customer service, the Group offers an array of brokerage services and asset management solutions. It is regulated across five continents by 18+ of the most reputable financial authorities globally. The group’s award-winning trading platforms offer up to 1000:1 leverage on a diverse range of products, including Forex, Metals, Shares, Commodities, Indices, and Cryptocurrencies. MultiBank Group has received over 80 financial awards recognizing its trading excellence and regulatory compliance. For more information, visit MultiBank Group’s www.multibankgroup.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803009139/en/

Permalink

https://aetoswire.com/en/news/0308202656583

Contacts

Nikolas Neofytou

Head of Direct Buys

nikolas.neofytou@multibankfx.com